Stockreport

Data Featuring Haystack MRD® from Quest Diagnostics to be Presented at the 2026 ASCO Gastrointestinal Cancers Symposium [Yahoo! Finance]

Quest Diagnostics Incorporated  (DGX) 
Last quest diagnostics incorporated earnings: 4/22 06:45 am Check Earnings Report
US:NYSE Investor Relations: ir.questdiagnostics.com
PDF that data will be shared on circulating tumor DNA (ctDNA) minimal residual disease (MRD) testing during two poster presentations at the 2026 ASCO Gastrointestinal Cancer [Read more]